Drug Trial Radar · NCT00011986
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Last checked: Nov 19, 2026Latest source record: Apr 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,312
Actual
Start
Jan 2001
Primary completion
Mar 2010
Study completion Jan 28, 2013
Sponsor
- Lead sponsor
- Gynecologic Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- SWOG Cancer Research Network; Medical Research Council; National Cancer Institute (NCI)
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.
Conditions
- Primary Peritoneal Carcinoma
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
Interventions
PaclitaxelDrug
Given IV
CarboplatinDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
Pegylated Liposomal Doxorubicin HydrochlorideDrug
Topotecan HydrochlorideDrug
Given IV
Therapeutic Conventional SurgeryProcedure
Undergo surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: Up to 9 years
- Progression-free SurvivalTime frame: From the date of enrollment to first progression or death or last contact, if alive and progression free.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Gynecologic Oncology Group
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.